Data / Form D filings / Synthetica Bio, Inc.
Synthetica Bio, Inc.: Form D filings
Synthetica Bio, Inc., a biotechnology company in Anaheim, CA, filed 4 Form D notices with the SEC in 2023. The latest, on August 29, 2023, reports $4.3 million sold of a $4.3 million offering to 16 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1950 W CORPORATE WAY, #12489, Anaheim, CA, 92801
- Phone
- (760) 470-4862
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1981956
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 29, 2023 | Amendment | $4,250,000 | $4,250,000 | 16 | May 30, 2023 | sec.gov | |
| Aug 2, 2023 | Amendment | $4,250,000 | $4,000,000 | $250,000 | 15 | May 30, 2023 | sec.gov |
| Jul 5, 2023 | Amendment | $3,000,000 | $2,500,000 | $500,000 | 13 | May 30, 2023 | sec.gov |
| Jun 16, 2023 | New notice | $3,000,000 | $1,325,000 | $1,675,000 | 4 | Jun 5, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Simon Arkell | Executive Officer, Director | |
| Alexander Dickinson | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Aug 28, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Synthetica Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.